Dr. Reddy's Laboratories Limited
RDY
$13.47
$0.060.45%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.00% | 1.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.00% | 1.61% | |||
| Cost of Revenue | 6.23% | -1.45% | |||
| Gross Profit | -2.96% | 4.07% | |||
| SG&A Expenses | 1.04% | 7.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 6.89% | 43.64% | |||
| Total Operating Expenses | 3.61% | 1.48% | |||
| Operating Income | -9.10% | 2.12% | |||
| Income Before Tax | -5.57% | -3.93% | |||
| Income Tax Expenses | -19.18% | 19.75% | |||
| Earnings from Continuing Operations | -0.78% | -10.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 24.32% | 25.67% | |||
| Net Income | -0.64% | -10.02% | |||
| EBIT | -9.10% | 2.12% | |||
| EBITDA | -6.32% | 9.11% | |||
| EPS Basic | -0.70% | -9.91% | |||
| Normalized Basic EPS | -8.63% | -5.69% | |||
| EPS Diluted | -0.65% | -9.88% | |||
| Normalized Diluted EPS | -8.57% | -5.70% | |||
| Average Basic Shares Outstanding | 0.08% | -0.14% | |||
| Average Diluted Shares Outstanding | 0.02% | -0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||